FDA Inspection
Oklahoma Blood Institute Arkansas Blood InstituteOklahoma Blood Institute Arkansas Blood Institute – FDA Inspection, Jul 20, 2018
Record Details
This FDA Inspection record concerns Oklahoma Blood Institute Arkansas Blood Institute, with an inspection on July 20, 2018, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- July 20, 2018
- Product Type
- Biologics
View Company Profile
ID · 620e8ad3-5e3b-45bb-af67-02c304a47923
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1060711
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 606.171Biological product deviation report
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Oklahoma Blood Institute Arkansas Blood Institute
4| Date | Classification | Office | Project area |
|---|---|---|---|
| February 6, 2025 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 28, 2022 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| October 19, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 6, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Oklahoma Blood Institute Arkansas Blood Institute
- FDA Inspection 1261481 - 2025-02-06
- FDA Inspection 1169916 - 2022-04-28
- FDA Inspection 989311 - 2016-10-19
- FDA Inspection 946357 - 2015-10-06
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.